Entera Bio Ltd
NASDAQ:ENTX
Entera Bio Ltd
Free Cash Flow
Entera Bio Ltd
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Entera Bio Ltd
NASDAQ:ENTX
|
Free Cash Flow
-$7.3m
|
CAGR 3-Years
12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Free Cash Flow
-$3.7m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Free Cash Flow
-$1.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
18%
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Free Cash Flow
-$22.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-2%
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Free Cash Flow
-$82.5m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Free Cash Flow
-₪27.2m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-12%
|
See Also
What is Entera Bio Ltd's Free Cash Flow?
Free Cash Flow
-7.3m
USD
Based on the financial report for Dec 31, 2023, Entera Bio Ltd's Free Cash Flow amounts to -7.3m USD.
What is Entera Bio Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
6%
Over the last year, the Free Cash Flow growth was 42%. The average annual Free Cash Flow growth rates for Entera Bio Ltd have been 12% over the past three years , 6% over the past five years .